Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 Positive Early or Locally Advanced Breast Cancer Who Have Completed the SB3-G31-BC

NCT02771795 is registered in ClinicalTrials.gov with Samsung Bioepis Co., Ltd. as lead sponsor.

NCT NCT02771795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02771795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 Positive Early or Locally Advanced Breast Cancer Who Have Completed the SB3-G31-BC
Lead sponsor
Samsung Bioepis Co., Ltd.
Phase
Observational
Overall status
Terminated
Start date
April 30, 2016
Completion date
December 31, 2020
Enrollment
538 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms